| Date Filed | Type | Description |
| 08/21/2023 |
4
| ZIEGLER JOSEPH (Principal Financial Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 08/21/2023 |
3
| ZIEGLER JOSEPH (Principal Financial Officer) has filed a Form 3 on TherapeuticsMD, Inc. |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2023 |
4
| Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 312,525 shares
@ $3.6797, valued at
$1.1M
|
|
| 05/04/2023 |
4/A
| Walker Marlan D (CEO) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 692 shares
@ $3.6381, valued at
$2.5k
Exercised 1,010 restricted stock units
@ $0
Exercised 1,734 restricted stock units
@ $0 |
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2023 |
4
| Walker Marlan D (CEO) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 70,000 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 50,000 restricted stock units
@ $0 |
|
| 02/22/2023 |
4/A
| Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Disposed/sold 29,000 shares
@ $1333, valued at
$38.7M
|
|
| 01/30/2023 |
4
| Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 1,648 shares
@ $5.0796, valued at
$8.4k
Sold 49 shares
@ $5.09, valued at
$249.4
Exercised 2,400 rights
@ $0
Exercised 1,140 rights
@ $0 |
|
| 01/25/2023 |
4
| Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 1,302 shares
@ $5.3383, valued at
$7k
Sold 7 shares
@ $5.3101, valued at
$37.2
Exercised 380 restricted stock units
@ $0
Exercised 1,066 restricted stock units
@ $0
Exercised 519 restricted stock units
@ $0
Exercised 2,400 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 29,000 shares
@ $1333, valued at
$38.7M
|
|
| 12/12/2022 |
4
| Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Bought 14,825 shares
@ $6.09, valued at
$90.3k
|
|
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Bought 20,113 shares
@ $5.6625, valued at
$113.9k
Bought 300 shares
@ $5.83, valued at
$1.7k
|
|
| 12/08/2022 |
4
| Naughton Gail K (Director) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 3,922 shares
@ $5.2614, valued at
$20.6k
|
|
| 10/31/2022 |
4
| Rubric Capital Management LP (10% Owner) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Bought 7,000 shares
@ $1000, valued at
$7M
|
|
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
3
| Bernick Brian (Co-CEO) has filed a Form 3 on TherapeuticsMD, Inc. |
| 08/31/2022 |
3
| Roberts Justin Hunter (Director) has filed a Form 3 on TherapeuticsMD, Inc. |
| 08/22/2022 |
4
| Collins Cooper C. (Director) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Exercised 1,984 restricted stock units
@ $0 |
|
|